Mercer Global Advisors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $209K | Sell |
7,573
-192
| -2% | -$5.3K | ﹤0.01% | 2032 |
|
|
2025
Q1 | $220K | Buy |
7,765
+371
| +5% | +$10.5K | ﹤0.01% | 1909 |
|
|
2024
Q4 | $307K | Sell |
7,394
-7,242
| -49% | -$301K | ﹤0.01% | 1726 |
|
|
2024
Q3 | $937K | Sell |
14,636
-8,442
| -37% | -$540K | ﹤0.01% | 1043 |
|
|
2024
Q2 | $2.72M | Sell |
23,078
-2,015
| -8% | -$238K | 0.01% | 625 |
|
|
2024
Q1 | $2.67M | Sell |
25,093
-11,221
| -31% | -$1.2M | 0.01% | 642 |
|
|
2023
Q4 | $3.61M | Sell |
36,314
-1,495
| -4% | -$149K | 0.01% | 556 |
|
|
2023
Q3 | $3.91M | Sell |
37,809
-31,053
| -45% | -$3.21M | 0.01% | 505 |
|
|
2023
Q2 | $8.37M | Buy |
68,862
+1,262
| +2% | +$153K | 0.03% | 331 |
|
|
2023
Q1 | $10.4M | Buy |
67,600
+2,945
| +5% | +$452K | 0.05% | 263 |
|
|
2022
Q4 | $11.6M | Buy |
64,655
+11,773
| +22% | +$2.11M | 0.06% | 244 |
|
|
2022
Q3 | $6.25M | Buy |
52,882
+20,278
| +62% | +$2.4M | 0.04% | 323 |
|
|
2022
Q2 | $4.66M | Buy |
32,604
+3,618
| +12% | +$517K | 0.03% | 389 |
|
|
2022
Q1 | $4.99M | Buy |
28,986
+11,905
| +70% | +$2.05M | 0.03% | 382 |
|
|
2021
Q4 | $4.34M | Buy |
17,081
+1,204
| +8% | +$306K | 0.03% | 410 |
|
|
2021
Q3 | $6.11M | Buy |
15,877
+9,337
| +143% | +$3.59M | 0.04% | 303 |
|
|
2021
Q2 | $1.54M | Buy |
6,540
+1,257
| +24% | +$295K | 0.01% | 670 |
|
|
2021
Q1 | $692K | Sell |
5,283
-359
| -6% | -$47K | 0.01% | 936 |
|
|
2020
Q4 | $589K | Sell |
5,642
-1,348
| -19% | -$141K | 0.01% | 800 |
|
|
2020
Q3 | $495K | Buy |
6,990
+2,643
| +61% | +$187K | 0.01% | 783 |
|
|
2020
Q2 | $279K | Buy |
+4,347
| New | +$279K | 0.01% | 874 |
|